S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

308

Participants

Timeline

Start Date

April 29, 2024

Primary Completion Date

October 31, 2031

Study Completion Date

October 31, 2031

Conditions
MTAP-deleted Solid Tumors
Interventions
DRUG

S095035

S095035 will be taken orally once daily in 28-day cycles.

DRUG

TNG462

TNG462 will be taken orally once daily in 28-day cycles.

Trial Locations (32)

2031

RECRUITING

Scientia Clinical Research, Randwick

2100

NOT_YET_RECRUITING

University Hospital Rigshospitalet, Copenhagen

3004

RECRUITING

The Alfred, Prahran

4812

NOT_YET_RECRUITING

Townsville University Hospital, Douglas

5000

NOT_YET_RECRUITING

Odense Universitets Hospital, Odense

7000

NOT_YET_RECRUITING

Royal Hobart Hospital, Hobart

8023

NOT_YET_RECRUITING

Next Oncology-Hospital Quironsalud Barcelona, Barcelona

8035

NOT_YET_RECRUITING

Hospital Vall D'Hebron, Barcelona

13353

NOT_YET_RECRUITING

Charite Universitatsmedizin, Berlin

20098

NOT_YET_RECRUITING

Instituto Clinico Humanitas Irccs, Rozzano

20141

NOT_YET_RECRUITING

Istituto Europeo Di Oncologia, Milan

21079

NOT_YET_RECRUITING

Centre Georges-François Leclerc, Dijon

27710

NOT_YET_RECRUITING

Duke University School of Medicine, Durham

28040

NOT_YET_RECRUITING

Hospital Universitario Fundación Jiménez Díaz, Madrid

28050

NOT_YET_RECRUITING

Start Madrid Group - Hm Ciocc, Madrid

32746

RECRUITING

Lake Mary Cancer Center - Florida Cancer Specialists & Research Institute, Lake Mary

33076

NOT_YET_RECRUITING

Institut Bergonié, Bordeaux

37134

NOT_YET_RECRUITING

Policlinico G.B. Rossi A.O.U.I. Di Verona, Verona

37203

RECRUITING

SCRI Oncology Partners, Nashville

40225

NOT_YET_RECRUITING

Universitätsklinikum Düsseldorf, Düsseldorf

43537

RECRUITING

Taylor Cancer Research Center, Maumee

46250

RECRUITING

Community Health Network, Indianapolis

69120

NOT_YET_RECRUITING

Med Fakultaet Heidelberg, Heidelberg

78758

RECRUITING

NEXT Oncology, Austin

80131

NOT_YET_RECRUITING

A.O.U. Seconda Università Degli Studi Di Napoli, Napoli

NOT_YET_RECRUITING

Ist. Nazionale Tumori Irccs Fondazione G Pascale, Napoli

89081

NOT_YET_RECRUITING

Universitätsklinikum Ulm, Ulm

90095

NOT_YET_RECRUITING

University of California Los Angeles, Los Angeles

94143

NOT_YET_RECRUITING

University of California, San Francisco (Ucsf) School of Medicine, San Francisco

1358550

RECRUITING

The Cancer Institute Hospital of JFCR, Tokyo

4648681

RECRUITING

Aichi Cancer Center, Aichi

7910280

NOT_YET_RECRUITING

National Hospital Organization Shikoku Cancer Center, Ehime

All Listed Sponsors
collaborator

Institut de Recherches Internationales Servier

OTHER

collaborator

Tango Therapeutics, Inc.

INDUSTRY

lead

Servier Bio-Innovation LLC

INDUSTRY